Gilead Sciences acquires Immunomedics in $21bn deal

Gilead Sciences acquires Immunomedics in $21bn deal

Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn. In September, Gilead signed a definitive merger agreement to acquire all the outstanding shares of Immunomedics at a price of $88 per...
Global Livestock Pain Management Market…

Global Livestock Pain Management Market…

Global Coronavirus pandemic has impacted all industries across the globe, Livestock Pain Management market being no exception. As Global economy heads towards major recession post 2009 crisis, Cognitive Market Research has published a recent study which meticulously...
Manufacturing Equipment Trends – Contract…

Pharmaceutical manufacturing is a growing…

Editor’s note: The N.C. Biotech Center and WRAL TechWire announced recently the launch of the Bio Jobs Hub, a project designed to match workers and employers in the growing NC life science community. Each Wednesday TechWire plans to feature a story about what’s...